These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 29135798
1. VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR AND GAS TAMPONADE FOR SUBFOVEAL HEMORRHAGE: Prognostic Factors and Clinical Outcomes. Plemel DJA, Lapere SRJ, Rudnisky CJ, Tennant MTS. Retina; 2019 Jan; 39(1):172-179. PubMed ID: 29135798 [Abstract] [Full Text] [Related]
11. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration. Gok M, Karabaş VL, Aslan MS, Kara Ö, Karaman S, Yenihayat F. Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713 [Abstract] [Full Text] [Related]
16. Massive subretinal and subretinal pigment epithelial hemorrhage displacement with perfluorocarbon liquid using a two-step vitrectomy technique. Fleissig E, Barak A, Goldstein M, Loewenstein A, Schwartz S. Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1341-1347. PubMed ID: 28412773 [Abstract] [Full Text] [Related]
18. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration. Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972 [Abstract] [Full Text] [Related]
19. Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration. Barayev E, Tiosano A, Zlatkin R, Elul R, Dotan A, Hadayer A, Gal-Or O, Ehrlich R. Eur J Ophthalmol; 2024 May; 34(3):825-833. PubMed ID: 37715632 [Abstract] [Full Text] [Related]